These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 18687018)

  • 21. Proposed DSM-5 mixed features are associated with greater likelihood of remission in out-patients with major depressive disorder.
    Perlis RH; Cusin C; Fava M
    Psychol Med; 2014 May; 44(7):1361-7. PubMed ID: 22417535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depression outcomes of Spanish- and english-speaking Hispanic outpatients in STAR*D.
    Lesser I; Rosales A; Zisook S; Gonzalez C; Flores D; Trivedi M; Sciolla A; Luther J; Wisniewski S; Alpert J; Cook I; Rush AJ; Epstein M
    Psychiatr Serv; 2008 Nov; 59(11):1273-84. PubMed ID: 18971403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utilizing the DSM-5 Anxious Distress Specifier to Develop Treatment Strategies for Patients With Major Depressive Disorder.
    J Clin Psychiatry; 2017; 78(9):1351-1362. PubMed ID: 29188904
    [No Abstract]   [Full Text] [Related]  

  • 24. Predictors of 12-week remission in a nationwide cohort of people with depressive disorders: the CRESCEND study.
    Kim JM; Kim SW; Stewart R; Kim SY; Yoon JS; Jung SW; Lee MS; Yim HW; Jun TY
    Hum Psychopharmacol; 2011 Jan; 26(1):41-50. PubMed ID: 21344501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diurnal mood variation in outpatients with major depressive disorder.
    Morris DW; Trivedi MH; Fava M; Wisniewski SR; Balasubramani GK; Khan AY; Jain S; Rush AJ
    Depress Anxiety; 2009; 26(9):851-63. PubMed ID: 19306304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incorporating multidimensional patient-reported outcomes of symptom severity, functioning, and quality of life in the Individual Burden of Illness Index for Depression to measure treatment impact and recovery in MDD.
    Cohen RM; Greenberg JM; IsHak WW
    JAMA Psychiatry; 2013 Mar; 70(3):343-50. PubMed ID: 23303512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D Trial.
    Arnow BA; Blasey C; Williams LM; Palmer DM; Rekshan W; Schatzberg AF; Etkin A; Kulkarni J; Luther JF; Rush AJ
    Am J Psychiatry; 2015 Aug; 172(8):743-50. PubMed ID: 25815419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Network analysis of the Quick Inventory of Depressive Symptomatology: Reanalysis of the STAR*D clinical trial.
    Madhoo M; Levine SZ
    Eur Neuropsychopharmacol; 2016 Nov; 26(11):1768-1774. PubMed ID: 27707535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in Depression Subtypes Among Men in STAR*D: A Latent Transition Analysis.
    Ulbricht CM; Dumenci L; Rothschild AJ; Lapane KL
    Am J Mens Health; 2018 Jan; 12(1):5-13. PubMed ID: 26438468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repetitive transcranial magnetic stimulation in combination with citalopram in young patients with first-episode major depressive disorder: a double-blind, randomized, sham-controlled trial.
    Huang ML; Luo BY; Hu JB; Wang SS; Zhou WH; Wei N; Hu SH; Xu Y
    Aust N Z J Psychiatry; 2012 Mar; 46(3):257-64. PubMed ID: 22391283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Residual symptoms of depression: clinical and theoretical implications.
    Boulenger JP
    Eur Psychiatry; 2004 Jun; 19(4):209-13. PubMed ID: 15196602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality of Life and Functioning in Comorbid Posttraumatic Stress Disorder and Major Depressive Disorder After Treatment With Citalopram Monotherapy.
    Steiner AJ; Boulos N; Mirocha J; Wright SM; Collison KL; IsHak WW
    Clin Neuropharmacol; 2017; 40(1):16-23. PubMed ID: 27764051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.
    Khan A; Bose A; Alexopoulos GS; Gommoll C; Li D; Gandhi C
    Clin Drug Investig; 2007; 27(7):481-92. PubMed ID: 17563128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-rated global measure of the frequency, intensity, and burden of side effects.
    Wisniewski SR; Rush AJ; Balasubramani GK; Trivedi MH; Nierenberg AA;
    J Psychiatr Pract; 2006 Mar; 12(2):71-9. PubMed ID: 16728903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Temporal multi-step predictive modeling of remission in major depressive disorder using early stage treatment data; STAR*D based machine learning approach.
    Salem H; Huynh T; Topolski N; Mwangi B; Trivedi MH; Soares JC; Rush AJ; Selvaraj S
    J Affect Disord; 2023 Mar; 324():286-293. PubMed ID: 36584711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome.
    Howland RH; Rush AJ; Wisniewski SR; Trivedi MH; Warden D; Fava M; Davis LL; Balasubramani GK; McGrath PJ; Berman SR
    Drug Alcohol Depend; 2009 Jan; 99(1-3):248-60. PubMed ID: 18986774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Remissions in maternal depression and child psychopathology: a STAR*D-child report.
    Weissman MM; Pilowsky DJ; Wickramaratne PJ; Talati A; Wisniewski SR; Fava M; Hughes CW; Garber J; Malloy E; King CA; Cerda G; Sood AB; Alpert JE; Trivedi MH; Rush AJ;
    JAMA; 2006 Mar; 295(12):1389-98. PubMed ID: 16551710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical features and drug induced side effects in early versus late antidepressant responders.
    Fabbri C; Marsano A; Balestri M; De Ronchi D; Serretti A
    J Psychiatr Res; 2013 Oct; 47(10):1309-18. PubMed ID: 23800418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum brain-derived neurotrophic factor levels at 6 months after remission are not associated with subsequent depressive episodes.
    Yoshimura R; Hori H; Sugita-Ikenouchi A; Umene-Nakano W; Katsuki A; Nakamura J
    J Clin Psychopharmacol; 2013 Feb; 33(1):142-3. PubMed ID: 23288242
    [No Abstract]   [Full Text] [Related]  

  • 40. Easing the burden of treatment-resistant depression.
    J Clin Psychiatry; 2009 Feb; 70(2):273-80. PubMed ID: 19265643
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.